Sunday, December 4, 2022
HomeLatest NewsFederal NewsOpioid bill awaits president’s signature

Opioid bill awaits president’s signature

Last week the Senate voted 98-1 to pass the major opioid legislative package it had negotiated with the House. The bill now awaits President Trump’s signature.

The House and Senate mostly agreed on major provisions of the legislation, however language that would let Medicare pay more for opioid alternatives that treat post-surgical pain did not make the final cut. Also not included was a fiscal offset that would have saved government funds by requiring employer-paid plans to cover more care for end-stage renal disease.

Click here to view a comparison of select provisions of the House and Senate bills and what was included in the final opioid bill.

Stay Connected

Unified Voice Newsletter

Events This Month

december

06dec11:00 am12:00 pmEarly Childhood Comprehensive Systems (ECCS) CollaborativeSDAHO Webinar

07dec12:00 pm1:00 pmRoP Interpretative Guidance: Phase 2 and Phase 3 – Select F-Tag ReviewSDAHO Webinar

08dec11:00 am12:00 pmPain Management & Practice GuidelinesSDAHO Webinar

08dec12:00 pm1:30 pmRural Emergency Hospital Designation: The Known and the UnknownSDAHO Webinar

13dec12:00 pm1:00 pmSolving for Staffing Challenges with Flexible, Virtual Care ModelsAHA Webinar


By submitting this form, you are consenting to receive marketing emails from: SDAHO, 3708 W Brooks Place, Sioux Falls, SD, 57106, http://sdaho.org. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact